Phase I/II study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non-small-cell lung cancer

A study was undertaken to determine the maximum tolerated dose, the dose-limiting toxicities and the response rate of carboplatin and 5-fluorouracil administered daily with concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer. In a phase I/II clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshizawa, H, Tanaka, J, Kagamu, H, Maruyama, Y, Miyao, H, Ito, K, Sato, T, Iwashima, A, Suzuki, E, Gejyo, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394482/
https://www.ncbi.nlm.nih.gov/pubmed/12942108
http://dx.doi.org/10.1038/sj.bjc.6601227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394482/
https://www.ncbi.nlm.nih.gov/pubmed/12942108
http://dx.doi.org/10.1038/sj.bjc.6601227

Ejemplares similares